G-5555|＞98%|abs819023-爱必信(上海)生物科技有限公司

G-5555

参考价：¥1512

供货周期：

一周

品牌：

爱必信

规格：

＞98%

货号：

abs819023

CAS号：

1648863-90-4

产品详情

公告提醒：爱必信所有产品和服务仅用于科学研究，不用于临床应用及其他用途提供产品和服务（也不为任何个人提供产品和服务）!

抑制剂描述：

产品名称：G-5555

产品别名：见爱必信官网

英文别名：G-5555

靶点：PAK

CAS：1648863-90-4

纯度：＞98%

外观：见爱必信官网

保存方法：Store at -20°C

描述：

G-5555 is a potent p21-activated kinase 1 (PAK1) inhibitor with Kis of 3.7 nM and 11 nM for PAK1 and PAK2, respectively.

溶解性：DMSO : ≥ 27 mg/mL (54.77 mM)

体外研究：

G-5555 is a potent PAK1 inhibitor with a Ki of 3.7 nM. G-5555 shows excellent kinase selectivity and inhibits only eight out of the 235 kinases tested other than PAK1 with inhibition >70%: PAK2, PAK3, KHS1, Lck, MST3, MST4, SIK2, and YSK1. The IC50s of G-5555 against SIK2, PAK2, KHS1, MST4, YSK1, MST3 and Lck are 9, 11, 10, 20, 34, 43, 52 nM, respectively. In general, G-5555 demonstrates high selectivity for the group I PAKs. There is negligible activity for G-5555 against the hERG channel with IC50 more than 10 μM in a patch clamp assay. G-5555 potently inhibits PAK2, with a Ki of 11 nM. In an array of 23 breast cancer cell lines, G-5555 has significantly greater growth inhibitory activity in cell lines that are PAK-amplified compared to non-amplified lines.

体内研究：G-5555 exhibits low blood clearance and an acceptable half-life. Good oral exposure (AUC = 30 μM?h) and high oral bioavailability (F = 80%) are achieved. In an H292 non-small cell lunger cancer (NSCLC) xenograft study in mice, G-5555 inhibits phosphorylation of the PAK1/2 downstream substrate mitogen-activated protein kinase 1 (MEK1) S298 and, when administered at an oral dose of 25 mg/kg b.i.d., imparts 60% tumor growth inhibition in this model13 and a PAK1 amplified breast cancer xenograft model, MDAMB-175.

产品信息订购：

产品货号	产品名称	规格	价格	大包装及货期
abs819023	G-5555	1mg	1512.00	立即咨询
abs819023	G-5555	5mg	3024.00	立即咨询

产品更多信息请进入爱必信网站咨询